Icon

BARACLUDE (nda021797)- (0.5MG,1MG)

ENTECAVIR BRISTOL MYERS SQUIBB
0.5MG,1MG
Yes No
2015-Aug-21 Expired
None None
None No
BARACLUDE is a hepatitis B virus nucleoside analogue reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection in adults and children at least 2 years of age with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
12 0 11
Total Other Developers 1
Drugs with Suitability No
0.5MG ** ** - - 9
1MG ** ** - - 8
NDA Sales Available Total Generic Sales Available
Yes 10
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** **** *** * ****** **** ******* *********** **** *, **. **.: ***, ***, *** & ***, ***** *********** ***, ********* *******, ************, ********* ******, ***** (***) ***
****** ****** ******** ****** ****** *** *********** ******** ******** ****, *** ********* ****, *********, , ******* (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ****** ****** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** ***** ****** ***** ************ ******* *********** **** **. *-*/*&* *******, (******* ******** ****) ******, ******* ***** *.*. **. **, ***-******, ****-*********, *********, ******* ******, ***** (***) ***
****** ***** ***** ******* *********** **** **. * &** ****** ******* ******** ****, ***** **, ********* ****, ****** ******* ******, ***** (***) ***
****** ***** ***** ******* *** *********** **** *-*, *-**, *-** **** ********** ****, ******** *******, ******-*****, ****, *********** ******, ***** (***) ***
****** **** **** ***** **** **** *****. ***. **., ***. (******** ***** *******) *********** **, **** **** **.,, ******** ****, *****, ****** (***) ***
****** ************ ******* ************ ******* *********** *** ****-* **** **. *-**/*, *-***, & *-***, **** **. **, *** ********, ***** ******, *******-**********, ********* ******, ***** (***) ***
****** ******** *** ******** ****** ************** **., ***. *********** ******* ****, ******, ******** ******, ***** (***) ***
****** ***** ***** ********* (******) **., ***. (****** *****) *********** **. **, ***** **., ****** ********** ****, ****** ****, ****** ********, ****** ****, ********* ******, ***** (***) ***
****** ********** ***** ************** **., ***. *********** ***-*, ****** ****., ******, ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.